+44 (0) 1223 755950
+1 832 327 7413
orders@abbexa.com
Click on the image to see the image legend
Target | Eotaxin (CCL11) |
Origin | Human |
Expression | Recombinant |
Tested Applications | SDS-PAGE |
Host | E. coli |
Conjugation | Unconjugated |
Form | Lyophilized |
Purity | > 97% (SDS-PAGE and RP-HPLC) |
Reconstitution | It is recommended to reconstitute the lyophilized Eotaxin Human Recombinant in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
Storage | Eotaxin should be stored desiccated below -18 °C. Upon reconstitution CCL11 should be stored at 4 °C between 2-7 days and for future use below -18 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P51671 (UniProt, ExPASy) |
UniProt Secondary AC | P50877, Q92490, Q92491 |
UniProt Entry Name | CCL11_HUMAN |
KEGG | hsa:6356 |
String | 9606.ENSP00000302234 |
Sequence | The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Pro-Ala-Ser-Val. |
Biological Activity | The activity is determined by the chemoattract of human PBE (peripheral blood eosinophils) at a concentration between.1-1 ng/ml corresponding to a Specific Activity of 1,-1,,IU/mg. |
Availability | Shipped within 5-10 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |